Reckitt Benckiser Group’s (RKT) “Hold” Rating Reaffirmed at HSBC

HSBC reissued their hold rating on shares of Reckitt Benckiser Group (LON:RKT) in a report released on Thursday morning, MarketBeat Ratings reports.

Reckitt Benckiser Group Trading Down 0.2 %

Shares of Reckitt Benckiser Group stock opened at GBX 4,130 ($51.41) on Thursday. The company has a debt-to-equity ratio of 100.80, a quick ratio of 0.46 and a current ratio of 0.64. Reckitt Benckiser Group has a 52 week low of GBX 4,102.64 ($51.07) and a 52 week high of GBX 6,570 ($81.79). The stock has a 50 day moving average price of GBX 4,895.57 and a two-hundred day moving average price of GBX 5,336.67. The stock has a market capitalization of £29.26 billion, a PE ratio of 1,823.35, a price-to-earnings-growth ratio of 3.76 and a beta of 0.07.

Reckitt Benckiser Group Increases Dividend

The business also recently announced a dividend, which will be paid on Friday, May 24th. Investors of record on Thursday, April 11th will be given a dividend of GBX 115.90 ($1.44) per share. This is a boost from Reckitt Benckiser Group’s previous dividend of $76.60. The ex-dividend date of this dividend is Thursday, April 11th. This represents a dividend yield of 1.99%. Reckitt Benckiser Group’s payout ratio is presently 8,502.20%.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; vaginal care routine products; sore throat medications; and hair removal products under the Clearasil, Dettol, Durex, Gaviscon, Nurofen, Mucinex, Queen V, Strepsils, and Veet brands.